Hypoglycemia in hospitalized patients treated with antihyperglycemic agents

Journal of Hospital Medicine

Volumn 2, Issue 4, 2007, Pages 234-240

  Varghese, Precil ^a   Gleason, Vanessa ^a   Sorokin, Rachel ^b,d   Senholzi, Craig ^a   Jabbour, Serge ^b   Gottlieb, Jonathan E ^c  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Adverse event; Anti hyperglycemic agents; Drug safety; Hypoglycemia; Insulin; Patient safety; Quality improvement; Sulfonylureas

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; GLUCOSE; INSULIN; METFORMIN; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA;

ADULT; AGED; ARTICLE; COMBINATION CHEMOTHERAPY; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INCIDENCE; INJURY; INSULIN DEPENDENT DIABETES MELLITUS; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SEIZURE; SYMPTOM; UNIVERSITY HOSPITAL;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; FEMALE; GLYCEMIC INDEX; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; MALE; MIDDLE AGED; PHILADELPHIA; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 34548500618     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.212     Document Type: Article

References (27)

1. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553-591.
2. Cryer PE, Davis SN, Shamoom H. Hypoglycemia in diabetes. Diabetes Care. 2003;26:1902-1912.
3. Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y. Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med. 1999;159:281-284.
4. Bates, DW. Unexpected hypoglycemia in a critically ill patient. Ann Intern Med. 2002;137:110-116.
5. Malouf R, Brust JCM. Hypoglycemia: causes, neurological manifestations and outcome. Ann Neurol. 1985;17:421-430.
6. Pomposelli JJ, Baxter JK III, Babineau TJ, et al. Early post-operative glucose control predicts nosocomial infection rate in diabetic patients. J Parenter Enteral Nutr. 1998;22:77-81.
7. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thor Surg. 1999;67:352-362.
8. Deepak PJ, Sunitha K, Nagaraj J, et al. Inpatient management of diabetes: survey in a tertiary care center. Postgrad Med J. 2003;79:585-587.
9. Kresevic DM, Slavin SM. Incidence of hypoglycemia and nutritional intake in patients on a general medical unit. Nursingconnections. 1989;2:33-40.
10. Queale WS. Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997;157:545-552.
11. Baldwin D, Villanueva G, McNutt R, Bhatnagar S. Eliminating sliding-scale insulin. Diabetes Care. 2005;28:1008-1011.
12. American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes. A report from the American Diabetes Association workgroup on hypoglycemia. Diabetes Care. 2005;28:245-1249.
13. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354: 449-461
14. Van den Berghe G; Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345:1359-1367.
15. Metchick LM, Petit WA, Inzucchi SE. Inpatient management of diabetes mellitus. Am J Med. 2002;113:317-323.
16. Garber AJ, Moghissi ES, Bransome ED, et al. American College of Endocrinology Position Statement on inpatient diabetes and metabolic Control Endo Pract. 2004;10:77-82.
17. Abourizk NN, Vora CK, Verma PK. Inpatient diabetology, the new frontier. J Gen Intern Med. 2004;19:466-471.
18. Inzucchi SE, Rosenstock J. Counterpoint: inpatient glucose management, a premature call to arms? Diabetes Care. 2005; 28:976-979.
19. Smith WD, Winterstein TJ, Rosenberg E, Sauer BC. Causes of hyperglycemia and hypoglycemia in adult inpatients. Am J Health Syst Pharm. 2005;62:714-719.
20. Fischer, KF, Lees, JA, Newman, JH. Hypoglycemia in hospitalized patients: causes and outcomes. N Engl J Med. 1986; 315:245-1250.
21. Available at: http://www.ismp.org/Tools/highalertmedications.pdf. Accessed July 27, 2006.
22. Joint Commission on Accreditation of Healthcare Organizations. High alert medications and patient safety. Sentinel Event Alert Issue 11, November 19, 1999 Available at: http://www.jointcommission.org/ SentinelEvents/SentinelEventAlert/sea_11.htm. Accessed July 27, 2006.
23. Harrower AD. Comparative tolerability of sulfonylureas in diabetes mellitus. Drug Saf. 2000;22:313-320.
24. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc. 1996;44:751-755
25. Groop LC, DeFronzo RA. Sulfonylureas. In: DeFronzo BA, ed. Current Management of Diabetes Mellitus. St. Louis, MO: Mosby; 1998:96-101.
26. Triplitt CL, Reasner CA, Isley WL. Diabetes Mellitus in Pharmacotherapy: A Pathophysiologic Approach. 6th ed. Dipiro JT, ed. New York: McGraw Hill; 2005.
27. Kanji S, Buffie J, Hutton B, et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33:2778-2785.